Deficiency of Micronutrients Clinical Trial
— ZestiVitsOfficial title:
A Study to Evaluate the Acceptability of ZestiVits; a New Vitamin, Mineral and Trace Element Supplement for Those Aged 11 and Over on a Ketogenic or Restricted Diet With Regard to Product Tolerance, Palatability and Compliance
Verified date | February 2024 |
Source | Vitaflo International, Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A study to evaluate the acceptability of ZestiVits; a new vitamin, mineral and trace element supplement for children aged 11 years and over and adults on a ketogenic or restricted therapeutic diet with regard to product tolerance, palatability and compliance.
Status | Completed |
Enrollment | 15 |
Est. completion date | August 31, 2018 |
Est. primary completion date | August 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 11 Years and older |
Eligibility | Inclusion Criteria: 1. Diagnosis of condition requiring a ketogenic or restrictive therapeutic diet 2. On a ketogenic or restricted therapeutic diet with good compliance 3. Aged 11 years and over 4. Has a requirement for a micronutrient supplement 5. Written informed consent by subject or parent/carer Exclusion Criteria: 1. Participants aged less than 11 years 2. Use of additional micronutrient supplements during the study period unless clinically indicated and prescribed by the investigator (must be recorded in patient case record file) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Bristol Royal Hospital for Children | Bristol | Avon |
United Kingdom | Leeds Children's Hospital | Leeds | West Yorkshire |
United Kingdom | Salford Royal NHS Foundation Trust | Salford | Greater Manchester |
Lead Sponsor | Collaborator |
---|---|
Vitaflo International, Ltd |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Palatability via qualitative assessments from a subject questionnaire | Qualitative outcome measures will be described in a narrative summarising the study outcomes | 7 days | |
Primary | Gastrointestinal tolerance via qualitative assessments from a subject questionnaire | Qualitative outcome measures will be described in a narrative summarising the study outcomes | 7 days | |
Primary | Patient compliance via qualitative assessments from a subject questionnaire | Qualitative outcome measures will be described in a narrative summarising the study outcomes | 7 days | |
Primary | Ease of use of product via qualitative assessments from a subject questionnaire | Qualitative outcome measures will be described in a narrative summarising the study outcomes | 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02543671 -
Investigation of Vitamin D3 Enriched, Reduced-fat Yellow Cheese Efficacy to Prevent Vitamin D Deficiency
|
N/A | |
Completed |
NCT02376140 -
Food Consumption and Iron Status Survey in Two Provinces of Rural Burkina Faso
|
N/A |